ICD-10-CM Billable Code

D25.2

Subserosal leiomyoma of uterus

Clinical Classification Guidelines

Inclusion Terms

  • Subperitoneal leiomyoma of uterus

Medical Intelligence & Overview

A subserosal leiomyoma of the uterus, also known as a subperitoneal leiomyoma, is a type of benign tumor that develops on the outer wall of the uterus within the muscle tissue. These growths are a common form of uterine fibroids, which are non-cancerous tumors that can vary in size and number. While they often do not cause symptoms, larger or multiple leiomyomas may lead to discomfort or other health issues.

Causes & Symptoms

Clinical Causes: Hormonal factors, especially estrogen and progesterone, which promote the growth of fibroids. Genetic predisposition, with a family history increasing risk. Ethnicity, with higher prevalence observed in women of African descent. Obesity, which can influence hormone levels. Age, particularly women aged 30 to 50, as fibroids tend to develop during the reproductive years. Certain lifestyle factors, such as diet and stress, may also play a role.

Key Symptoms: Pelvic pressure or pain, especially if the fibroid enlarges. Feeling of fullness or heaviness in the lower abdomen. Menstrual irregularities, including heavier or prolonged periods. Lower backache or leg pain in some cases. Frequent urination due to pressure on the bladder. Constipation if the fibroid presses against the rectum. Many women with subserosal leiomyomas experience no symptoms and may only discover them during routine examinations.

Diagnostic & Treatment

Diagnosis Path: Diagnosis often involves a combination of medical history, physical examination, and imaging tests. An ultrasound is the most common initial method to visualize uterine fibroids and determine their size and location. In some cases, MRI or hysterosonography may be utilized for more detailed assessment. A healthcare provider may also perform a pelvic exam to identify or evaluate the size and shape of the uterus.

Treatment Protocols: Treatment options depend on the size, number, symptoms, and the patient's reproductive plans. They include: - **Observation:** Monitoring with regular check-ups if the fibroid is small and asymptomatic. - **Medications:** Such as hormone therapy to shrink fibroids or manage symptoms, including gonadotropin-releasing hormone (GnRH) agonists. - **Minimally invasive procedures:** Including uterine artery embolization, which cuts off blood supply to the fibroid. - **Surgical options:** Myomectomy to remove fibroids while preserving the uterus or hysterectomy if removal of the entire uterus is appropriate. - **Alternative therapies:** Lifestyle modifications and herbal treatments are sometimes considered, but their effectiveness varies. It is essential to consult healthcare professionals to determine the most suitable approach based on individual circumstances.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D25.2 a billable ICD-10 code?
Yes, D25.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D25.2?
Clinical documentation must specify the nature of Subserosal leiomyoma of uterus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

uterus leiomyoma subserosal